SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form SC 13G/A - Statement of Beneficial Ownership by Certain Investors: [Amend]
SEC Accession No. 0001172661-24-001205
Filing Date
2024-02-14
Accepted
2024-02-14 14:07:36
Documents
1

Document Format Files

Seq Description Document Type Size
1 rocksprings-agle123123a1.htm SC 13G/A 87516
  Complete submission text file 0001172661-24-001205.txt   89265
Mailing Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202
Business Address 650 SOUTH EXETER STREET SUITE 1070 BALTIMORE MD 21202 4102200129
Rock Springs Capital Management LP (Filed by) CIK: 0001595725 (see all company filings)

IRS No.: 800944416 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A

Mailing Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453
Business Address 221 CRESCENT STREET BUILDING 23, SUITE 105 WALTHAM MA 02453 6176515940
Spyre Therapeutics, Inc. (Subject) CIK: 0001636282 (see all company filings)

IRS No.: 464312787 | State of Incorp.: DE | Fiscal Year End: 1231
Type: SC 13G/A | Act: 34 | File No.: 005-89456 | Film No.: 24635911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)